Region-specific loss of glutamate innervation in Alzheimer's disease

Synaptosomal D-aspartate has been used as a marker for glutamate neurons in control and in postmortem Alzheimer's disease brains. This technique shows a marked (60%) decrease of the glutamate uptake site in cortical and hippocampal regions. There were no significant changes in subcortical regions. We interpret these results as indicating loss of, or damage to, cortical glutamatergic innervation. These losses probably represent the biochemical correlate of pyramidal neuron damage in Alzheimer's disease.

[1]  V. Balcar,et al.  THE STRUCTURAL SPECIFICITY OF THE HIGH AFFINITY UPTAKE OF l‐GLUTAMATE AND l‐ASPARTATE BY RAT BRAIN SLICES , 1972, Journal of neurochemistry.

[2]  R. Schwarcz,et al.  Post-mortem high affinity glutamate uptake in human brain , 1982, Neuroscience.

[3]  B. Winblad,et al.  Transmitter deficits in Alzheimer's disease , 1985, Neurochemistry International.

[4]  D. Mann,et al.  Correlation between senile plaque and neurofibrillary tangle counts in cerebral cortex and neuronal counts in cortex and subcortical structures in Alzheimer's disease , 1985, Neuroscience Letters.

[5]  T. Crow,et al.  Location of neuronal tangles in somatostatin neurones in Alzheimer's disease , 1985, Nature.

[6]  E. Perry,et al.  Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of meynert in Alzheimer's disease , 1982, Neuroscience Letters.

[7]  D. Neary,et al.  Amino acid release from biopsy samples of temporal neocortex from patients with Alzheimer's disease , 1983, Brain Research.

[8]  D. Neary,et al.  AN ULTRASTRUCTURAL ANALYSIS OF THE EFFECTS OF ACCUMULATION OF NEUROFIBRILLARY TANGLE IN PYRAMIDAL NEURONS OF THE CEREBRAL CORTEX IN ALZHEIMER'S DISEASE , 1986, Neuropathology and applied neurobiology.

[9]  D. Price,et al.  Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease , 1986, Nature.

[10]  Calcium content of mice brain lipids during myelination , 1976, Neuroscience Letters.

[11]  J. Hardy,et al.  Metabolically Active Synaptosomes Can Be Prepared from Frozen Rat and Human Brain , 1983, Journal of neurochemistry.

[12]  F. Fonnum,et al.  THE EFFECT OF INTRAHIPPOCAMPAL KAINIC ACID INJECTIONS AND SURGICAL LESIONS ON NEUROTRANSMITTERS IN HIPPOCAMPUS AND SEPTUM , 1978, Journal of neurochemistry.

[13]  T. Jessell,et al.  Release of dopamine from dendrites in rat substantia nigra , 1976, Nature.

[14]  D. Bowen,et al.  Biochemical studies of nerve cells and energy metabolism in Alzheimer's disease. , 1986, British medical bulletin.

[15]  J. Hardy,et al.  Uptake of γ‐Aminobutyric Acid and Glycine by Synaptosomes from Postmortem Human Brain , 1986 .

[16]  J. Hardy,et al.  Use of post-mortem human synaptosomes for studies of metabolism and transmitter amino acid release , 1982, Neuroscience Letters.

[17]  J. Penney,et al.  Alterations in L-glutamate binding in Alzheimer's and Huntington's diseases. , 1985, Science.

[18]  R. H. Evans,et al.  Excitatory amino acid transmitters. , 1981, Annual review of pharmacology and toxicology.

[19]  M. Rossor.  Neurotransmitters and CNS disease. Dementia. , 1982, Lancet.

[20]  C. Cotman,et al.  Plasticity of hippocampal circuitry in Alzheimer's disease. , 1985, Science.

[21]  J. Hardy,et al.  A rapid method for preparing synaptosomes: Comparison, with alternative procedures , 1981, Brain Research.